|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02219 CHAOJU EYE CARE
Nominal 
2.730 -0.010 (-0.365%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 698,258 | -4.907% | 1,405,454 | 1,369,505 | 990,044 | 997,787 |
| Cost of Sales | (400,591) | 0.572% | (794,152) | (748,371) | (555,347) | (549,113) |
| Gross Profit | 297,667 | -11.402% | 611,302 | 621,134 | 434,697 | 448,674 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (353) | -33.895% | (2,028) | (5,835) | (3,957) | (13,608) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 153,090 | -14.780% | 262,723 | 299,242 | 239,138 | 210,582 | |
| Taxation | (42,351) | -7.973% | (76,513) | (78,507) | (55,942) | (52,941) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,904 | 2.506% | 8,866 | 8,179 | 4,556 | 4,108 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 113,643 | -16.716% | 195,076 | 228,914 | 187,752 | 161,749 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (12,358) | -26.971% | (28,930) | (29,085) | (11,077) | 2,218 |
| Depreciation & Amortisation | 73,704 | 1.427% | 144,161 | 123,361 | 99,366 | 83,522 |
| Directors' Emoluments | -- | -- | 6,664 | 6,013 | 4,323 | 5,161 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 16.000 | -20.000% | 28.000 | 33.000 | 27.000 | 26.000 |
| DPS (cts) | 0.000 | -- | 23.074 | 26.984 | 15.227 | 8.478 |
| Dividend Payout Ratio (%) | -- | -- | 82.405% | 81.770% | 56.396% | 32.609% |
| Cash flow per share ($) | -- | -- | 0.514 | 0.536 | 0.387 | 0.399 |
| NBV per share ($) | 3.326 | -- | 3.272 | 3.335 | 3.212 | 2.976 |
| Remarks: | Real time quote last updated: 11/09/2025 17:49 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 113,643 |
| %Change | -16.716% |
| EPS / (LPS) | RMB 0.160 |
| NBV Per Share (¥) | RMB 3.326 |